Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2009-03-11
2011-12-27
Aeder, Sean E (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
Reexamination Certificate
active
08084200
ABSTRACT:
The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
REFERENCES:
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 5227158 (1993-07-01), Jardieu
patent: 5521073 (1996-05-01), Davis et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5545807 (1996-08-01), Surani et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5571894 (1996-11-01), Wels et al.
patent: 5587458 (1996-12-01), King et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5641756 (1997-06-01), Robinson
patent: 5641870 (1997-06-01), Rinderknecht
patent: 5650490 (1997-07-01), Davis et al.
patent: 5661016 (1997-08-01), Lonberg et al.
patent: 5750373 (1998-05-01), Garrard et al.
patent: 5814464 (1998-09-01), Davis et al.
patent: 6150117 (2000-11-01), Zetter et al.
patent: 6348350 (2002-02-01), Goddard et al.
patent: 6372491 (2002-04-01), Goddard et al.
patent: 6455496 (2002-09-01), Goddard et al.
patent: 6475753 (2002-11-01), Ruben et al.
patent: 6582959 (2003-06-01), Kim et al.
patent: 6627741 (2003-09-01), Ruben et al.
patent: 6673545 (2004-01-01), Faris et al.
patent: 6680175 (2004-01-01), Blaschuk et al.
patent: 6703020 (2004-03-01), Thorpe et al.
patent: 6756219 (2004-06-01), Ishizaki et al.
patent: 6884879 (2005-04-01), Baca et al.
patent: 7368254 (2008-05-01), Jorgensen et al.
patent: 7371384 (2008-05-01), Gerber
patent: 2002/0119463 (2002-08-01), Faris et al.
patent: 2003/0055006 (2003-03-01), Siemeister et al.
patent: 2003/0065151 (2003-04-01), Ruben et al.
patent: 2003/0190317 (2003-10-01), Baca et al.
patent: 2003/0199058 (2003-10-01), Baker et al.
patent: 2003/0203409 (2003-10-01), Kim
patent: 2003/0206899 (2003-11-01), Ferrara et al.
patent: 2003/0207348 (2003-11-01), Shimkets et al.
patent: 2003/0207350 (2003-11-01), Baker et al.
patent: 2003/0207351 (2003-11-01), Baker et al.
patent: 2003/0207352 (2003-11-01), Baker et al.
patent: 2003/0207353 (2003-11-01), Baker et al.
patent: 2003/0207356 (2003-11-01), Baker et al.
patent: 2003/0207357 (2003-11-01), Baker et al.
patent: 2003/0207359 (2003-11-01), Baker et al.
patent: 2003/0207360 (2003-11-01), Baker et al.
patent: 2003/0207371 (2003-11-01), Baker et al.
patent: 2003/0207374 (2003-11-01), Baker et al.
patent: 2003/0207375 (2003-11-01), Baker et al.
patent: 2003/0207376 (2003-11-01), Baker et al.
patent: 2003/0207389 (2003-11-01), Baker et al.
patent: 2003/0207422 (2003-11-01), Baker et al.
patent: 2003/0207423 (2003-11-01), Baker et al.
patent: 2003/0207424 (2003-11-01), Baker et al.
patent: 2003/0207425 (2003-11-01), Baker et al.
patent: 2003/0207426 (2003-11-01), Baker et al.
patent: 2003/0207427 (2003-11-01), Baker et al.
patent: 2003/0208055 (2003-11-01), Baker et al.
patent: 2003/0215451 (2003-11-01), Ferrara et al.
patent: 2003/0219885 (2003-11-01), Baker et al.
patent: 2004/0133357 (2004-07-01), Pingyu et al.
patent: 2004/0249141 (2004-12-01), Goddard et al.
patent: 2005/0112126 (2005-05-01), Baca et al.
patent: 2005/0123925 (2005-06-01), Ashkenazi et al.
patent: 2005/0233361 (2005-10-01), Clerc et al.
patent: 2005/0239706 (2005-10-01), Backhed et al.
patent: 2006/0093607 (2006-05-01), Gerber et al.
patent: 2006/0222645 (2006-10-01), Lee et al.
patent: 2007/0026002 (2007-02-01), Gerber et al.
patent: 1315451 (2001-10-01), None
patent: 1343725 (2002-04-01), None
patent: 0 666 868 (2002-04-01), None
patent: 1 403 367 (2004-03-01), None
patent: 2000-308488 (2000-11-01), None
patent: WO 93/11161 (1993-06-01), None
patent: WO 93/16185 (1993-08-01), None
patent: WO 94/10202 (1994-05-01), None
patent: WO 96/30046 (1996-10-01), None
patent: WO 98/45331 (1998-10-01), None
patent: WO 98/45332 (1998-10-01), None
patent: WO99/15653 (1999-04-01), None
patent: WO99/15654 (1999-04-01), None
patent: WO 99/32515 (1999-07-01), None
patent: WO 99/45135 (1999-09-01), None
patent: WO 99/66041 (1999-12-01), None
patent: WO 99/67382 (1999-12-01), None
patent: WO 00/52165 (2000-09-01), None
patent: WO00/53753 (2000-09-01), None
patent: WO 00/61629 (2000-10-01), None
patent: WO 00/63380 (2000-10-01), None
patent: WO 01/02429 (2001-01-01), None
patent: WO 01/05825 (2001-01-01), None
patent: WO 01/05971 (2001-01-01), None
patent: WO01/40466 (2001-06-01), None
patent: WO 01/40466 (2001-06-01), None
patent: 01/53455 (2001-07-01), None
patent: 01/53486 (2001-07-01), None
patent: WO 01/54477 (2001-08-01), None
patent: WO 01/57188 (2001-08-01), None
patent: WO 01/77151 (2001-10-01), None
patent: WO 02/77013 (2002-10-01), None
patent: WO 02/101039 (2002-12-01), None
patent: WO 03/000865 (2003-01-01), None
patent: WO 03/010205 (2003-02-01), None
patent: WO 03/025138 (2003-03-01), None
patent: WO 03/040329 (2003-05-01), None
patent: WO 03/040330 (2003-05-01), None
patent: WO 03/048185 (2003-06-01), None
patent: WO 03/060071 (2003-07-01), None
patent: WO 03/103581 (2003-12-01), None
patent: WO2004/045516 (2004-06-01), None
patent: WO 2005/012359 (2005-02-01), None
patent: WO 2005/044853 (2005-05-01), None
patent: WO 2006/014678 (2006-02-01), None
patent: WO 2006/014729 (2006-02-01), None
patent: WO 2006/014729 (2006-02-01), None
“Supplementary European Search Report mailed Dec. 28, 2010 in European Application No. 03783432.2”.
Costello, at al., “Dissection of the Inflammatory Bowel Disease Transciptome Using Genome-Wide cDNA microarrays”PLOS Medicine2 (8) : 771-787 (Aug. 2005).
Gieseg, et al., “Expression profiling of human renal carcinomas with functional taxonomic analysis”BMC Bioinformatics3 (26) : 1-13 (Sep. 2002).
Morimoto, “Gene expression profiling of human colon xenograft tumors following treatment with SU11248, a multitargeted tyrosine kinase inhibitor”Oncogene23:1618-1626 (2004).
Munro, et al., “E-Cadherin and OB-Cadherin mRNA Levels in Normal Human Colon and Colon Carcinoma”Experimental and Molecular Pathology62:118-122 (1995).
Oremek, et al., “The Pyruvate Kinase Isoenzyme Tumor M2 (Tu M2-PK) as a Tumor Marker for Renal Carcinoma”Anticancer Research19 (4A) :2599-2601 (Jul. 1999).
UniProtKB/Swiss-Prot entry P55287, 2011.
Vila, at al., “Increased Glyceraldehyde-3 Phosphate Dehydrogenase Expression in Renal Cell Carcinoma Identified by RNA-Based, Arbitrarily Primed Polymerase Chain Reaction”Cancer89 (1) :152-164 (Jan. 1, 2000).
Mandard et al., “The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment” J Biol Chem. 279(33):34411-34420, (2004).
Mandard et al., “The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity” J Biol Chem. 281(2):934-944, (2006).
Marshall et al., “The role of alpha v-integrins in tumour progression and metastasis” Semin Cancer Biol. 7(3):129-138, (1996).
Melnyk et al., “Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth” Cancer Research 56(4):921-924, (1996).
Mesiano et al., “Role of Vascular Endothelial Growth Factor in Ovarian Cancer: Inhibition of Ascites Formation by Immunoneutralization” American Journal of Pathology vol. 153, No. 4 pp. 1249-1256 (1998), XP002373802, ISSN: 0002-9440.
Millauer, “Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo” Cancer Research 56(7):1615-1620, (1996).
Millauer, “Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant” Nature 67(6463): 576-579, (1994).
Minn et al., “Genes that mediate breast cancer metastasis to lung” Nature 436(7050):518-524, (2005).
Mitani et al., “Delivering therapeutic genes-matching approach and application” TIBTECH 11(5):162-166 (1993).
Morgan and Anderson, “Human gene therapy” Annu Rev Bi
Ashkenazi Avi J.
Frantz Gretchen
Goddard Audrey
Gonzalez Lino
Gurney Austin L.
Aeder Sean E
Arnold & Porter LLP
Bernhardt Jeffery P.
Genentech Inc.
Kalinowski Grant
LandOfFree
Compositions and methods for the diagnosis and treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for the diagnosis and treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the diagnosis and treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4295383